4//SEC Filing
KLEIN JOSEPH III 4
Accession 0000874015-25-000286
CIK 0000874015other
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 5:51 PM ET
Size
20.7 KB
Accession
0000874015-25-000286
Insider Transaction Report
Form 4
KLEIN JOSEPH III
Director
Transactions
- Exercise/Conversion
Common Stock
2025-11-25+4,000→ 4,000 total(indirect: By Trust) - Sale
Common Stock
2025-11-25$80.00/sh−4,000$320,000→ 0 total(indirect: By Trust) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-11-25−4,000→ 8,000 total(indirect: By Trust)Exercise: $60.20From: 2021-07-01Exp: 2030-06-30→ Common Stock (4,000 underlying)
Holdings
- 16,346
Common Stock
- 100(indirect: by Son)
Common Stock
Footnotes (3)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on January 3, 2024
- [F2]The reporting person disclaims beneficial ownership of all securities held in the children's trusts, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F3]The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001206369
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 5:51 PM ET
- Size
- 20.7 KB